Skip to content

Albuterol vs Ephedrine: side-by-side comparison

Fat Burner

Salbutamol · Ventolin · ProAir

A selective beta-2 adrenergic agonist, roughly 29-fold more selective for beta-2 vs beta-1 receptors. Often considered a safer alternative to clenbuterol due to a much shorter half-life (5-6 hrs vs ~26-48 hrs) and better cardiac profile. Works through the cAMP pathway to promote lipolysis and exhibits anti-catabolic effects by inhibiting calpain (a muscle protein-degradation enzyme). Rat studies show a 19% muscle mass increase and 12-39% fat reduction; the effect in humans is real but far more modest.

5.0/10 natty
Full breakdown →
VS
Fat Burner

Ephedra · ECA Stack · Ma Huang

A sympathomimetic amine that works through both direct beta-receptor activation and indirect norepinephrine release to increase thermogenesis and metabolic rate. The classic fat burner, often stacked with caffeine and aspirin (ECA stack). The JAMA meta-analysis of ephedra/ephedrine trials shows ~0.9 kg/month weight loss above placebo. Carries significant cardiovascular risks.

5.0/10 natty
Full breakdown →

5 / 10 natty scale / 5

Same lane

Both sit in the same class and are run for cutting, performance. This is a like-for-like comparison: read the gaps as real trade-offs.

The tape

Core ratings

The same three rulers every entry on the site is scored with, read head to head.

AlbuterolEphedrine
5.0

Natty scale

1 natural · 10 heavy

5.0
3.0

Effectiveness

Documented effect · of 5Δ1

4.0
2.0

Side-effect severity

Documented burden · of 5Δ1

3.0

Cost side

Body-load fingerprint

Where each one actually lands its strain, on the calculator's thirteen channels. Tap a row for what it means and which labs track it.

AlbuterolEphedrine

Cardiometabolic

Organ strain

Systemic

Bars show strain at each one's typical protocol, not your dose. marks values inferred from side-effect data or category rather than hand-graded. For your numbers, run the calculator.

Logistics

The vitals

AlbuterolEphedrine
Fat Burner
Classmatch
Fat Burner
Oral
Routematch
Oral
4-16 mg/day2-3x daily oral tablets, space doses evenly (immediate-release ~5-6h half-life).
Typical dose
20-75 mg/daySplit into 2-3 doses/day (commonly 20-25mg per dose); ranges above are total daily amounts. Avoid afternoon/evening dosing due to insomnia.
5-6 hours (oral); 3.8-5 hours (inhaled)
Half-life
3-6 hours
4-8 weeks
Typical run
4-12 weeks
Prescription only
Legal status
Controlled substance
ProhibitedS3. Beta-2 Agonists
WADAmatch
ProhibitedS6. Stimulants

Benefit side

What each is for

Shared goals carry both dots; a goal with one dot belongs to that side alone.

AlbuterolEphedrine
CuttingPerformance

Run for

Fat LossStimulates beta-2 receptors to increase energy expenditure and lipolysis. Beta-2 agonists can raise resting metabolic rate meaningfully in the short term, but controlled human data show a modest effect (e.g. one RCT found fat-mass loss in trained women but not men over 6 weeks). Treat it as a mild-to-moderate assist alongside diet, not a dramatic fat-loss driver.
Anti-Catabolic/Muscle PreservationInhibits calpain (muscle degradation enzyme) via cAMP/calpastatin. Rat studies: 19% increase in hindlimb muscle weight. Controlled human trials in muscular dystrophy patients (DEXA-measured) showed statistically significant, modest lean-mass gains and fat-mass reductions over 12 weeks to a year of use.
Safer Clenbuterol Alternative5-6 hour half-life (vs roughly 26-48 hrs for clen) allows the body to recover overnight. No cardiac lesions have been documented for albuterol at therapeutic doses, unlike the cardiac fibrosis/hypertrophy seen with chronic clenbuterol in animal models.
BronchodilationPrimary FDA-approved use. Opens airways within 5 minutes when inhaled. 7th most prescribed medication in USA.

Documented upside

  • Shorter half-life than clenbuterol (5-6 hrs vs roughly 26-48 hrs)
  • Better cardiac safety profile - no cardiac lesions documented
  • FDA-approved for human use (unlike clen in USA)
  • Slower tolerance development - can use longer before cycling
  • Anti-catabolic: inhibits calpain, preserves muscle
+3 more on the full page

Run for

Fat Loss/ThermogenesisThe JAMA meta-analysis (Shekelle et al. 2003) found ~0.9 kg/month weight loss above placebo (0.6-1.3 kg/month across combinations), alongside a 5-10% increase in energy expenditure. In the landmark 24-week Astrup et al. (1992) RCT, the ephedrine+caffeine group lost 16.6 kg vs 13.2 kg with placebo (3.4 kg more, p=0.0015).
Appetite SuppressionApproximately 75% of ECA stack's fat loss efficacy is attributed to decreased appetite. Only 25% from thermogenic effects.
Muscle Preservation During CuttingStudies show ephedrine + caffeine users lose more fat mass and less lean body mass compared to controls during weight loss.
Energy/StimulationCNS stimulant effects provide energy and focus for training during caloric deficit.

Documented upside

  • Meta-analysis (Shekelle et al. 2003, JAMA): ~0.9 kg/month weight loss above placebo (0.6-1.3 kg/month range)
  • Increases energy expenditure by 5-10%
  • 75% of effect from appetite suppression
  • Preserves lean mass during weight loss
  • Synergistic with caffeine (ECA stack)
+3 more on the full page

The downsides

Side effects, aligned

Each entry's documented side effects, sorted onto the same body systems so the gaps and the overlaps are visible. Tap any effect for the detail.

AlbuterolEphedrine
Heart
Mood, sleep & CNS
Other documented effects

The exit

Hormonal fallout & recovery

What each does to your own hormone axis while on, and what leaving it costs.

AlbuterolEphedrine
Not required
PCT
Not required
While-on only
What sticks
While-on only

Albuterol

Does not affect HPT axis. No PCT required. Receptor downregulation occurs - cycle off 2+ weeks between uses.

Ephedrine

Does not affect HPT axis. No PCT required.

Read-out

How they separate

  1. 01

    Enhancement

    They land at almost the same point on the natty scale (5/10 vs 5/10): a similar distance beyond natural.

  2. 02

    Side-effect bill

    Ephedrine's documented side-effect severity is heavier (3/5 vs 2/5). The body-load fingerprint above shows where that weight actually lands.

  3. 03

    Body load

    The widest gap at typical protocols is heart structure (Ephedrine 6.4/10 vs 2.8/10).

  4. 04

    Coming off

    Neither requires PCT: both leave the natural testosterone axis running.

  5. 05

    Logistics

    typical runs are 4-8 weeks vs 4-12 weeks.

  6. 06

    Tested athletes

    Both are WADA-prohibited: neither belongs anywhere near tested competition.

Generated from each entry's data file. Descriptive, not a recommendation; nothing here is medical advice.